April 2, 2024

Revealing the Latest Prostate Cancer Insights and Innovation at AUA2024!

Revealing the Latest Prostate Cancer Insights and Innovation at AUA2024!

MyProstateScore 2.0 (MPS2) is a urine test designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7) by analyzing a comprehensive array of 18 unique gene transcripts.

Come see us at Booth #801 during AUA2024 and discover how a 30-second urine sample can give you personalized insights to guide your patients.